// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Frequency and Impact of Acute Stent Deformation After PCI of Left Main Coronary Artery Disease: An EXCEL trial intravascular ultrasound substudy

Song-Yi Kim - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Left main disease

Everolimus

Long-term valve function 5-9 years after transcatheter aortic valve implantation: data from the UK-TAVI Registry. On behalf of the National Institute for Cardiovascular Outcomes Research (NICOR)

Daniel Blackman - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Aortic regurgitation

N/A

Clinical Relevance of Functionally Insignificant Moderate Coronary Artery Stenosis Assessed by 3-vessel Fractional Flow Reserve Measurement

Jonghanne Park - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Comparison of Quantitative Flow Ratio and Fractional Flow Reserve to Identify Myocardial Ischemia: Validation With Myocardial Perfusion Scintigraphy and Cardiovascular Magnetic Resonance

Jelmer Westra - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Off-pump Versus On-pump Coronary Artery Bypass Surgery for Left Main Revascularization: Insights From the EXCEL trial

Umberto Benedetto - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Ischemic stroke

Everolimus

What is the Value of a Second Internal Thoracic Arterial Graft on 3-year Outcomes After CABG in Left Main Disease? Insights from the EXCEL trial

Daniel Thuijs - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Left main disease

Everolimus

Impact of the Timing of P2Y12 Inhibitor Discontinuation Prior to CABG in Patients with Left Main Disease: Results from the EXCEL Trial

Christopher Kelly - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Left main disease

Clopidogrel bisulfate

Impact of Post-Discharge Dual Antiplatelet Therapy vs. Aspirin Alone After CABG in Patients with Left Main Disease: Results from the EXCEL Trial

Christopher Kelly - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Left main disease

Aspirin

Outcomes of Left Main Revascularization in the Elderly and Younger Patients: The EXCEL trial

Erick Schampaert - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Everolimus

What Biomarker Threshold for Periprocedural Myocardial Infarction Following PCI and CABG in Left Main Disease is Prognostically Relevant? Analysis from the EXCEL Trial

Shmuel Chen - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

Everolimus

Incidence, Predictors, and Outcomes of New-Onset Atrial Fibrillation and Flutter After PCI or CABG for Left Main Disease: Analysis From the EXCEL Trial

Ioanna Kosmidou - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

Everolimus

Outcomes After Left Main PCI Versus CABG According to Ostial/Shaft Versus Distal Bifurcation Involvement: Insights From the EXCEL Trial

Anthony Gershlick - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Everolimus

Impact of Staging Percutaneous Coronary Intervention in Left Main Artery Disease: Insights From the EXCEL Trial

Carlos Collet - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Left main disease

Everolimus

Provisional vs. Planned Two-stent Technique in Patients with Distal Bifurcation Left Main Disease Undergoing PCI: The EXCEL Trial

David Kandzari - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Left main disease

Everolimus

Procedural Strategy and Clinical Outcomes in Patients Undergoing PCI for Left Main Trifurcation Disease: The EXCEL trial

David Kandzari - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Everolimus

Tradeoff between Myocardial Infarction and Bleeding in Relation to Bleeding Risk: insights from PARIS registry

Sabato Sorrentino - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Myocardial infarction

N/A

Culprit lesion versus multi-vessel intervention in patients with cardiogenic shock complicating myocardial infarction: Incidence and outcomes from The London Heart Attack Group

Krishnaraj Rathod - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Transcatheter Aortic Valve Replacement with a Self-Expanding Prosthesis or Surgical Aortic Valve Replacement in Intermediate-Risk Patients: Complete 1-Year Outcomes from the SURTAVI Trial

Nicolas Van Mieghem - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Peri-procedural Myocardial Infarction and Mortality in Patients Undergoing PCI vs. CABG for Left Main Disease: Analysis from the EXCEL Trial

Ori Ben-Yehuda - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Myocardial infarction

Everolimus

Impact of Discharge Location After Transcatheter Aortic Valve Replacement On 1-Year Outcomes In Women: Results From The WIN-TAVI Registry

Julinda Mehilli - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved